Dr. Rebecca Coutts, Senior Director of Pharmaceutical Development at PCI Pharma Services, shares expert insights on the changing approach to the development of highly potent oncology drug products.
With over 25 years of experience with specialist expertise in the development and processing of highly potent molecules, I currently hold the role of Senior Director of Pharmaceutical Development for PCI Pharma Services at its Tredegar site, which is a Center of Excellence for Development & Manufacturing services of both non-potent and highly potent oral solid drug products.
My new role focuses on leading our Pharmaceutical Development service offering for solid oral and liquid products. Through our capabilities and scientific expertise in potent handling at PCI, we are best positioned to offer our customers state-of-the-art development, manufacturing, and analytical testing at all stages of the drug product lifecycle.
As part of the pharmaceutical industry, we are experiencing rapid changes and advances in the molecular understanding of cancer. An increased focus on developing targeted therapies and regulatory support for getting novel treatments to market quickly transforms the approach to developing highly potent oncology drug products. Advanced automated technology and digital tools are key to safely handling and rapidly developing these complex, highly potent products. Utilizing the latest containment technologies enables handling products with an Occupational Exposure Limit (OEL) as low as 0.01μg/m3.
We are using digital technology and data analysis in each development phase, enabling scientists to accommodate various product requirements and adapt to different formulation and process challenges. Providing access to an extensive range of processing equipment ensures that these challenges can be addressed and suitable solutions for each unique project can be provided.
We are committed to supporting clients at every stage of the manufacturing cycle, delivering best-in-class services efficiently and effectively.
Find out more about our fully integrated Development Services.
